This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spencer Valero, L. M.
Right arrow Articles by Holder, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spencer Valero, L. M.
Right arrow Articles by Holder, A. A.

 Previous Article  |  Next Article 

Infect Immun, August 1998, p. 3925-3930, Vol. 66, No. 8
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Passive Immunization with Antibodies against Three Distinct Epitopes on Plasmodium yoelii Merozoite Surface Protein 1 Suppresses Parasitemia

Lilian M. Spencer Valero, Solabomi A. Ogun, Suzanne L. Fleck, Irene T. Ling, Terry J. Scott-Finnigan, Michael J. Blackman, and Anthony A. Holder*

Division of Parasitology, National Institute for Medical Research, London NW7 1AA, United Kingdom

Received 10 February 1998/Returned for modification 31 March 1998/Accepted 6 May 1998

We have produced monoclonal antibodies against Plasmodium yoelii merozoite surface protein 1 (MSP-1) and have assessed their ability to suppress blood stage parasitemia by passive immunization. Six immunoglobulin G antibodies were characterized in detail: three (B6, D3, and F5) were effective in suppressing a lethal blood stage challenge infection, two (B10 and G3) were partially effective, and one (B4) was ineffective. MSP-1 is the precursor to a complex of polypeptides on the merozoite surface; all of the antibodies bound to this precursor and to an ~42-kDa fragment (MSP-142) that is derived from the C terminus of MSP-1. MSP-142 is further cleaved to an N-terminal ~33-kDa polypeptide (MSP-133) and a C-terminal ~19-kDa polypeptide (MSP-119) comprised of two epidermal growth factor (EGF)-like modules. D3 reacted with MSP-142 but not with either of the constituents MSP-133 and MSP-119, B4 recognized an epitope within the N terminus of MSP-133, and B6, B10, F5, and G3 bound to MSP-119. B10 and G3 bound to epitopes that required both C-terminal EGF-like modules for their formation, whereas B6 and F5 bound to epitopes in the first EGF-like module. These results indicate that at least three distinct epitopes on P. yoelii MSP-1 are recognized by antibodies that suppress parasitemia in vivo.


* Corresponding author. Mailing address: Division of Parasitology, National Institute for Medical Research, Mill Hill, London NW7 1AA, United Kingdom. Phone: (44) 181 959 3666, ext. 2175. Fax: (44) 181 913 8593. E-mail: aholder{at}nimr.mrc.ac.uk.


Infect Immun, August 1998, p. 3925-3930, Vol. 66, No. 8
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Lynch, M. M., Cernetich-Ott, A., Weidanz, W. P., Burns, J. M. Jr. (2009). Prediction of Merozoite Surface Protein 1 and Apical Membrane Antigen 1 Vaccine Efficacies against Plasmodium chabaudi Malaria Based on Prechallenge Antibody Responses. CVI 16: 293-302 [Abstract] [Full Text]  
  • Faber, B. W., Remarque, E. J., Morgan, W. D., Kocken, C. H. M., Holder, A. A., Thomas, A. W. (2007). Malaria Vaccine-Related Benefits of a Single Protein Comprising Plasmodium falciparum Apical Membrane Antigen 1 Domains I and II Fused to a Modified Form of the 19-Kilodalton C-Terminal Fragment of Merozoite Surface Protein 1. Infect. Immun. 75: 5947-5955 [Abstract] [Full Text]  
  • BONILLA, J. A., VALIDUM, L., CUMMINGS, R., PALMER, C. J. (2006). GENETIC DIVERSITY OF PLASMODIUM VIVAX PVCSP AND PVMSP1 IN GUYANA, SOUTH AMERICA. Am J Trop Med Hyg 75: 830-835 [Abstract] [Full Text]  
  • Narum, D. L., Ogun, S. A., Batchelor, A. H., Holder, A. A. (2006). Passive Immunization with a Multicomponent Vaccine against Conserved Domains of Apical Membrane Antigen 1 and 235-Kilodalton Rhoptry Proteins Protects Mice against Plasmodium yoelii Blood-Stage Challenge Infection.. Infect. Immun. 74: 5529-5536 [Abstract] [Full Text]  
  • Pleass, R. J., Ogun, S. A., McGuinness, D. H., van de Winkel, J. G. J., Holder, A. A., Woof, J. M. (2003). Novel antimalarial antibodies highlight the importance of the antibody Fc region in mediating protection. Blood 102: 4424-4430 [Abstract] [Full Text]  
  • Stanisic, D. I., Martin, L. B., Good, M. F. (2003). The Role of the 19-kDa Region of Merozoite Surface Protein 1 and Whole-Parasite-Specific Maternal Antibodies in Directing Neonatal Pups' Responses to Rodent Malaria Infection. J. Immunol. 171: 5461-5469 [Abstract] [Full Text]  
  • Wipasa, J., Hirunpetcharat, C., Mahakunkijcharoen, Y., Xu, H., Elliott, S., Good, M. F. (2002). Identification of T Cell Epitopes on the 33-kDa Fragment of Plasmodium yoelii Merozoite Surface Protein 1 and Their Antibody-Independent Protective Role in Immunity to Blood Stage Malaria. J. Immunol. 169: 944-951 [Abstract] [Full Text]  
  • Near, K. A., Stowers, A. W., Jankovic, D., Kaslow, D. C. (2002). Improved Immunogenicity and Efficacy of the Recombinant 19-Kilodalton Merozoite Surface Protein 1 by the Addition of Oligodeoxynucleotide and Aluminum Hydroxide Gel in a Murine Malaria Vaccine Model. Infect. Immun. 70: 692-701 [Abstract] [Full Text]  
  • Ahlborg, N., Ling, I. T., Howard, W., Holder, A. A., Riley, E. M. (2002). Protective Immune Responses to the 42-Kilodalton (kDa) Region of Plasmodium yoelii Merozoite Surface Protein 1 Are Induced by the C-Terminal 19-kDa Region but Not by the Adjacent 33-kDa Region. Infect. Immun. 70: 820-825 [Abstract] [Full Text]  
  • Kedzierski, L., Black, C. G., Coppel, R. L. (2000). Immunization with Recombinant Plasmodium yoelii Merozoite Surface Protein 4/5 Protects Mice against Lethal Challenge. Infect. Immun. 68: 6034-6037 [Abstract] [Full Text]  
  • Narum, D. L., Ogun, S. A., Thomas, A. W., Holder, A. A. (2000). Immunization with Parasite-Derived Apical Membrane Antigen 1 or Passive Immunization with a Specific Monoclonal Antibody Protects BALB/c Mice against Lethal Plasmodium yoelii yoelii YM Blood-Stage Infection. Infect. Immun. 68: 2899-2906 [Abstract] [Full Text]  
  • Ahlborg, N., Ling, I. T., Holder, A. A., Riley, E. M. (2000). Linkage of Exogenous T-cell Epitopes to the 19-Kilodalton Region of Plasmodium yoelii Merozoite Surface Protein 1 (MSP119) Can Enhance Protective Immunity against Malaria and Modulate the Immunoglobulin Subclass Response to MSP119. Infect. Immun. 68: 2102-2109 [Abstract] [Full Text]